Plenary Sessions

The Scientific Program includes 15 Plenary Sessions:

Plenary Sessions on Monday, September 11, 2023

P1 Complementary approaches to stress related diseases: connecting multi-site imaging, experimental imaging, machine learning and epigenetics

(Symposium of the Max-Planck-Institut für Psychiatrie, Munich, Germany)

Chair: Philipp Sämann und Angelika Erhardt-Lehmann

1. ENIGMA & Hippocampal Subfields, Philipp Sämann
2. BrainAGE predictions in multisite studies, Adyasha Khuntia
3. Imaging Stress Test, Mira Erhart
4. Anxiety and Epigenetics, Angelika Erhardt-Lehmann

P2 Challenges and perspectives in the treatment of anxiety disorders – a clinical update

(Symposium of the Gesellschaft für Angstforschung e.V., Wasserburg am Inn, Germany)

Chair: Peter Zwanzger

1. Anxiety, sleep and stress, Martin Hatzinger
2. Digital approaches in the treatment of anxiety disorders – opportunities and limitations, Peter Zwanzger
3. Anxiety and the COVID-19 pandemic, Antonia Bendau

P3 Stress in neurological conditions (Dr. med Edda Neele-Stiftung Symposium)

Chair: Peter Riederer and Thomas Brücke

1. Is ADHD a risk for Alzheimer’s and Parkinson’s disease? Linked via oxidative stress and inflammation? Edna Grünblatt
2. MSA, a multiple stress disorder, Gregor Wenning
3. BPSD in dementia, Jens Benninghoff
4. Stress and dystonia, Dirk Dressler

P4 Women & Stress

Chair: Birgit Derntl and Andreas Fallgatter

1. Stress hormone dynamics and reproductive states, Vibe Frokjaer
2. Hormonal contraception and stress reactivity, Birgit Derntl
3. Exposure to childhood maltreatment and systemic inflammation across pregnancy: the role of psychological and physical sequelae of maltreatment, Theresa Kleih
4. Individuals at risk of adverse birth experiences, Thorsten Mikoteit
5. New CB-PTSS treatment strategies, Déborah Fort

P5 Psychobiological mechanisms of social stress and social buffering

Chair: Beate Ditzen and Grit Hein

Introduction and Discussion: On possible interventions to improve social buffering, Beate Ditzen

1. Social buffering in virtual reality and real life, Grit Hein
2. Neurobiological mechanisms underpinning opioid use disorder, Sara Kroll
3. Thermoregulation of social stress – experimental findings, Susanne Fischer
4. Blood transcriptome analysis suggests an indirect molecular association of early life adversities and adult social anxiety disorder by immune-related signal transduction, Susanne Edelmann

P6 Stress, Anxiety and Covid-19

Chair: Christian Jacob and Meichun Mohler-Kuo

1. The longitudinal association between parents’ stress, children’s stress and children’ anxiety during the covid pandemic in Switzerland, Meichun Mohler-Kuo
2. Predicting stress, fatigue, mood, and hair cortisol in two COVID-19 lockdowns, Aljoscha Dreisörner
3. Pregnant women and the COVID-19 pandemic, Rita Amiel Castro
4. Exposure to COVID-19-related hospitalization and death in a national sample of Swiss adolescents: prevalence and effects on anxiety and depression symptoms, Simon Foster

Plenary Sessions on Tuesday, September 12, 2023

P7 ADHD and stress under different perspectives, what we can learn from translational research

Lecture details and speakers

Chair: Stefano Pallanti and Susanne Walitza

1. Oxidative stress and inflammation in ADHD? Personalized in vitro modeling and treatments effects, Edna Grünblatt
2. Emotional dysregulation in ADHD, and treatment outcome. A summary of the evidence, Stefano Pallanti
3. Climate change impact on ADHD? Thomas Müller
4. Update on ADHD in females, Ana Buadze

P8 Primary and secondary prevention of youth suicide

Chair: Gregor Berger and Isabelle Häberling

1. Trajectories of suicidal ideation in children and adolescents with major depressive disorder, Isabelle Häberling
2. Suicide prevention programs in the state of Zurich, Martina Blaser
3. An innovation journey towards normalizing mental health training for young people, Eva Richterich
4. AdoSSIP – A short intervention program for youth after suicide attempts, Gregor Berger

P9 Zurich translates Stress: New findings on understanding and treating stress from the HMZ flagship project STRESS

Chair: Johannes Bohacek and Birgit Kleim

1. Unsupervised profiling of stress-induced behavioral changes in rodents, Johannes Bohacek
2. Neural emotion-regulation development and stress: A two-way street, Reka Borbas & Mirjam Habegger
3. Resilience in the face of stress: Investigating the neurobiological correclates of emotional conflict and arousal in a preregistered prospective cohort study, Laura Meine & Ella McPherson
4. Modulating arousal: what we have learned – and still have to learn – from pupil-based feedback, Sarah Meissner

P10 Anxiety, depression and loneliness

Chair: Jens Benninghoff and Josef Jenewein

1. Depression and anxiety in the elderly, Jens Benninghoff
2. Factors contributing to resilience using the example of cancer patients, Josef Jenewein
3. Future time perspective and depression, anxiety and stress in adulthood, Mathias Allemand
4. New insights into neurobiological mechanisms in adolescent depression, David Willinger
5. Facing Anxiety Together – The Success Factors of Peer-to-Peer Support, Irene Bruns

P11 Stress and psychological trauma: Risk and mechanisms for multiple health conditions

Chair: Mustafa al´Absi and Roland von Känel

Introductory remarks on early life adversity, traumatic stress, and health, Mustafa al´Absi

1. Posttraumatic stress disorder induced by cardiac disease, Roland von Känel
2. Anxiety and stress in the perspective of psychocardiology, Malte Meesmann
3. Adverse childhood experiences have been prospectively associated with cardiovascular disease, Annie Ginty
4. Mindful based intervention to address PTSD in unhoused women with substance use disorder, Dana Rose Garfin
5. Cardiovascular responding to stress, Siobhan Howard

P13 New insights in aetiology and therapy of anxiey, depression and stress related disorders (Symposium of the SGAD)

Details on the symposium and summary of the lectures 1-3

Chair: Annette Brühl and Martin Hatzinger

1. Environmental factors in offspring of parents with mood disorders and their role in parent–child transmission: findings from a 14 year prospective high risk study, Martin Preisig
2. Biomarker-guided antidepressant therapy, Martin Hatzinger
3. Brain Stimulation in stress-related, anxiety and affective disorders – an overview, Annette Brühl
4. How to deal with treatment resistent depression? Therapeutic drug monitoring, pharmacogenetics and rapid-acting antidepressants, Andreas Menke

P14 Everyday Life Stress

Chair: Nida Ali and Urs Nater

1. Examining fatigue and chronic stress in adults: From lab to life, Nida Ali
2. Investigating diurnal cortisol across the menstrual cycle, Elise Bücklein
3. Stress and migration, Rojan Amini-Nejad

P15 Plenary Session: Stress and different aspects of anxiety

Chair: Tatyana Strekalova and Dorothée Bentz

1. Omega-3 food supplement exerts anti-depressant and anti-anxiety effects in a mouse model of stress-induced juvenile depression, Tatyana Strekalova
2. Anxiety and medical disorders, Andri Andri
3. Hair endocannabinoids and glucocorticoids in youth with MDD and healthy controls, Andreas Walther
4. Influence of valproic acid combined with reactivation of fear memory on outcome of extinction-based therapy in patients with spider phobia, Dorothée Bentz
5. Objective biomarkers for diagnosis and prognosis for neuropsychiatric disorders: a metabolomics approach, Daniel Anthony